Seòmar agus comataidhean

We have received a share of UK PPRS receipts amounting to £8.5 million (2013-14), £49.8 million (2014-15) and £80.6 million (2015-16). Receipts include amounts relating to the 2009 and 2014 PPRS agreements and historic cash payments. Final income for 2016-17 is not currently available.

The New Medicines Fund provides financial support to NHS boards for End of Life, Orphan and Ultra Orphan medicines which can be accessed by patients in a number of ways such as by Individual Patient Treatment Requests, Peer Approved Clinical System or appropriate medicines accepted by Scottish Medicines Consortium. The Scottish Government does not hold all of this information centrally in the format requested. However, the treatment of more than 1,000 patients has been supported through the Rare Conditions Medicines Fund and its replacement, The New Medicines Fund.

The Scottish Government allocated £21.7million to the Rare Conditions Medicines Fund for the period 1 March 2013 to 31 March 2014, £21.5million to the New Medicines Fund for the period 1 April 2014 to 31 March 2015, and £85million to the New Medicines Fund for the period 1 April 2015 to 31 March 2016, with scope for further allocations of £5 million if required.

Scottish Government Officials meet with officials from the Department of Health and the other Devolved Administrations on a regular basis to discuss a wide range of issues including the operation of the Pharmaceutical Price Regulation Scheme. The last meeting was held on Monday 12 September 2016.

Information on the requested breakdown of expenditure is not available centrally.

This information is not held centrally.

In general, Independent Living Fund (ILF) Scotland does not support people in supported accommodation as it is tasked with supporting disabled people in an independent living setting. There are some limited exceptions to this, where an ILF assessor judges that someone lives sufficiently independently in a shared care environment; however the ILF Scotland management information system does not provide sufficient level of detail to allow separate data on support to these individuals to be extracted.

There is no specific guidance on the number of safety mats required in residential care accommodation. A safety mat should be provided where an individual has been assessed and a requirement for one has been identified. The Care Inspectorate expect people's needs to be assessed before they move into a care home and if a safety mat or pressure mat is needed, that this is provided.

The Scottish Government is currently working to develop a new Child and Adolescent Health and Wellbeing strategy. This will be produced in Autumn 2017 following a period of consulting with key stakeholders.

The 125 to 208 beds figure in the question will likely be derived from the Royal College of Psychiatrists’ Report CR182, Building and sustaining specialist CAMHS to improve outcomes for children and young people.

It is the responsibility of health boards to provide services appropriate to the needs of their local population. Children and young people referred to Child and Adolescent Mental Health Services (CAMHS) will be generally treated in the community. There may however be times when it is necessary to admit them to hospital for specialist treatment. Should this be the case they would be admitted to one of the 3 regional CAMHS inpatient units or the national unit for under 12s. These units are a highly specialist service. The young people’s units are planned on a regional basis, with the boards collaborating across three regions. The under 12s unit is planned on a national basis.

There are no current plans to increase the bed base of the 6 place unit for 5-12 years olds following a review of this service in November 2014 which found that, since 2009, the bed occupancy (excluding day patient beds) ranged from 47% in both 2009-10 and 2010-11 to 28% at its lowest.

The bed base for the North of Scotland region for 12 to 18 year olds increased from 6 to 12 in 2015.

Preparatory work for the Scottish Centre for Deep Brain Stimulation is being carried out by the host board NHS Greater Glasgow and Clyde.

The Scottish Government expects the service to be implemented in Spring 2017, but this will be dependent on key posts being recruited and equipment being in place.